Fair Value of Financial Instruments (Tables)

12 Months Ended

Mar. 26, 2016

Fair Value of Financial Instruments [Abstract]

Schedule of Fair Value of Financial Assets and Liabilities

	Quoted Prices
	in Active		Significant
	Markets for		Other		Significant
	Identical		Observable		Unobservable
	Assets		Inputs		Inputs
	Level 1		Level 2		Level 3		Total
Assets:
Cash equivalents
Money market funds	$	79,256	$	-	$	-	$	79,256
Available-for-sale securities
Corporate debt securities	$	-	$	81,213	$	-	$	81,213
Liabilities:
Other accrued liabilities
Contingent consideration	$	-	$	-	$	4,709	$	4,709
Other long-term liabilities
Contingent consideration	$	-	$	-	$	4,359	$	4,359

The following summarizes the fair value of our financial instruments at March 28, 2015 (in thousands):

	Quoted Prices
	in Active		Significant
	Markets for		Other		Significant
	Identical		Observable		Unobservable
	Assets		Inputs		Inputs
	Level 1		Level 2		Level 3		Total
Cash equivalents
Money market funds	$	996	$	-	$	-	$	996
Available-for-sale securities
Corporate debt securities	$	-	$	153,836	$	-	$	153,836
U.S. Treasury securities		27,995		-		-		27,995
Commercial paper		-		2,487		-		2,487
	$	27,995	$	156,323	$	-	$	184,318

Schedule of Fair Value of Financial Instruments Contingent Consideration

		Maximum Value if Milestones Achieved (in thousands)	Estimated Discount Rate (%)		Fair Value (in thousands)
Tranche A - 18 month earn out period	$	5,000	7.3	$	4,709
Tranche B - 30 month earn out period		5,000	7.7		4,359
	$	10,000		$	9,068

Schedule of Fair Value of Contingent Consideration Rollforward

	Fiscal year ended
	March 26,
	2016
Beginning balance	$	-
Acquisition addition		8,600
Loss recognized in earnings (research and development expense)		468
Ending balance	$	9,068